Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · Real-Time Price · USD
9.46
+0.11 (1.18%)
At close: Aug 25, 2025, 4:00 PM
9.01
-0.45 (-4.76%)
After-hours: Aug 25, 2025, 7:10 PM EDT
Artelo Biosciences Market Cap
Artelo Biosciences has a market cap or net worth of $12.50 million as of August 25, 2025. Its market cap has increased by 191.23% in one year.
Market Cap
12.50M
Enterprise Value
10.31M
1-Year Change
191.23%
Ranking
Category
Stock Price
$9.46
Market Cap Chart
Since November 14, 2017, Artelo Biosciences's market cap has increased from $5.88M to $12.50M, an increase of 112.76%. That is a compound annual growth rate of 10.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 12.36M | 261.16% |
| Dec 31, 2024 | 3.42M | -23.37% |
| Dec 29, 2023 | 4.46M | -45.90% |
| Dec 30, 2022 | 8.25M | -62.41% |
| Dec 31, 2021 | 21.95M | 99.02% |
| Dec 31, 2020 | 11.03M | 19.25% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 14, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 638.90B |
| Johnson & Johnson | 431.79B |
| AbbVie | 372.04B |
| UnitedHealth Group | 278.42B |
| Novo Nordisk | 253.97B |
| AstraZeneca | 251.25B |
| Novartis AG | 246.51B |
| Abbott Laboratories | 230.77B |